99% Savings - Buy Just @1 Rs X
Imigem 250 Injection is a prescription medicine that is available as a Injection. Secondary and off-label uses of Imigem 250 Injection have also been mentioned below.
The right dosage of Imigem 250 Injection depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Imigem 250 Injection side effects, there are can be others also. These have been listed below. Normally, these side effects of Imigem 250 Injection are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Imigem 250 Injection is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Imigem 250 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Imigem 250 Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease, Kidney Disease as it can result in adverse effects. Other conditions have been mentioned below in the Imigem 250 Injection contraindications section.
Drug reaction of Imigem 250 Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Imigem 250 Injection, it is important to know that it is safe while driving, and is habit-forming.
Imigem 250 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Imigem 250 Injection safe for pregnant women?
Imigem can have harmful effects in pregnant women. If you experience any discomfort after using Imigem, then discontinue the use and take your doctor's advice.
Is the use of Imigem 250 Injection safe during breastfeeding?
Imigem may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Imigem, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Imigem.
What is the effect of Imigem 250 Injection on the Kidneys?
There may be some adverse effects on kidney after taking Imigem. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Imigem 250 Injection on the Liver?
The liver can be affected by Imigem. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Imigem only after medical advice.
What is the effect of Imigem 250 Injection on the Heart?
Side effects of Imigem rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Imigem 250 Injection unless your doctor advises you to do so -
Is this Imigem 250 Injection habit forming or addictive?
Imigem 250 Injection does not cause addiction.
Interaction between Food and Imigem 250 Injection
Eating certain foods may increase the time it takes Imigem 250 Injection to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Imigem 250 Injection
Consult your doctor before consuming alcohol while taking Imigem 250 Injection as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678